Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Rivaroxaban MeSH Descriptor Data 2026


MeSH Heading
Rivaroxaban
Tree Number(s)
D02.886.778.727
D03.383.533.640.713
D03.383.903.727
Unique ID
D000069552
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000069552
Scope Note
A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME.
Entry Term(s)
5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide
BAY 59-7939
Xarelto
Pharm Action
Factor Xa Inhibitors
Registry Numbers
9NDF7JZ4M3
0
Public MeSH Note
2016; RIVAROXABAN was indexed under MORPHOLINES and THIOPHENES 2005-2015
History Note
2016 (2005)
Date Introduced
2016/01/01
Last Updated
2016/05/31
Rivaroxaban Preferred
BAY 59-7939 Narrower
Xarelto Narrower
page delivered in 0.157s